Keywords: DFO، deferoxamine; CCB, calcium channel blocker; HSCs, hepatic stellate cells; DFO, deferoxamine; Tf, transferrin; TfR, transmembrane transferrin receptor; Ft, ferritin; LVDCCs, L-type voltage-dependent calcium channels; DMT-1, divalent metal transporter-1; ECM, extracellul
مقالات ISI DFO، deferoxamine (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DFO، deferoxamine; Apoptosis; Endoplasmic reticulum (ER) stress; Lipotoxicity; INS-1 beta cell; Iron; PalmitateATF6, activating transcription factor-6; CHOP, C/EBP homologous protein; DFO, deferoxamine; DS, deferasirox; ER, endoplasmic reticulum; FFA, free fatty acid; FTH,
Keywords: DFO، deferoxamine; APMA, aminopropyl methacrylamide; ASCs, Adipose Stem Cells; BMP, bone morphogenetic protein; CCL-5, chemokine ligand-5; DA, Diels–Alder; DFO, deferoxamine; DMOG, dimethyloxallyl glycine; ECFC, endothelial colony-forming cells; ECM, extra cellular matrix;
Keywords: DFO، deferoxamine; DFO, deferoxamine; KTp4-Me, potassium tris(4-methyl-1-pyrazolyl)-borohydride; ROS, reactive oxygen species; HCC, hepatocellular carcinoma; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet
Keywords: DFO، deferoxamine; CHX, cycloheximide; DFO, deferoxamine; DMOG, dimethyloxalylglycine; EDTA, ethylenediaminetetraacetic acid; FBS, fetal bovine serum; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HIF-1α, hypoxia-inducible factor-1 alpha; ODD, oxygen degradatio
The action of HIF-3α variants on HIF-2α–HIF-1β heterodimer formation is directly probed in live cells
Keywords: DFO، deferoxamine; bHLH, basic helix-loop-helix; DFO, deferoxamine; FRET, fluorescence resonance energy transfer; HIF, hypoxia-inducible factor; IPAS, inhibitory PAS domain; ODDD, oxygen-dependent degradation domain; PAS, Per-ARNT-Sim; PHD, prolyl hydroxylase; TAD, transact
Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in HepG2 cells
Keywords: DFO، deferoxamine; ARS, artesunate; ART, artemisinin; ARTs, ART compounds; BSO, L-buthionine-sulfoximine; CCK-8, Cell Counting Kit-8; DCF-DA, 2′,7′-dichlorodihydrofluorescein diacetate; DHA, dihydroartemisinin; DFO, deferoxamine; FITC, fluorescein isothiocyanate; FCM, flow
Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease
Keywords: DFO، deferoxamine; DFO, deferoxamine; IN, intranasal; 6-OHDA, 6 hydroxydopamine; PD, Parkinson׳s disease; AD, Alzheimer׳s disease; TH IR, tyrosine hydroxylase immunoreactive; PBS, phosphate buffered saline; ICV, intracerebroventricular; LIP, labile iron pool; GSK3β, glycoge
Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain
Keywords: DFO، deferoxamine; Aβ, amyloid-β; AD, Alzheimer’s disease; APP, amyloid precursor protein; CDK5, cyclin dependent kinase 5; DFO, deferoxamine; DMT1, divalent metal transporter 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GSK3β, glycogen synthase kinase 3β; HRP, horse
Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: Implication in autosomal recessive juvenile Parkinsonism
Keywords: DFO، deferoxamine; AR-JP, autosomal recessive familial Parkinsonism; DFO, deferoxamine; DAergic, dopaminergic; EC, epicathecin; EGCG, epigallocathecin gallate; GA, gallic acid; GFP, green fluorescent protein; OS, oxidative stress; PQ, Paraquat; PD, Parkinson's disease; PG,
TNF-α-stimulated macrophages protect A549 lung cells against iron and oxidation
Keywords: DFO، deferoxamine; AMs, alveolar macrophages; AMC, 7-amino-4-methyl-coumarin; AO, acridine orange; DFO, deferoxamine; ELF, epithelial lining fluid; GAPDH, glycerylaldehyde-3-phosphate dehydrogenase; γ-GCS, γ-glutamylcysteine synthetase; GO, glucose oxidase; GSH, reduced glu
The role of HIF in cobalt-induced ischemic tolerance
Keywords: DFO، deferoxamine; ANOVA, analysis of variance; DAPI, 4,6-diamidino-2-phenylindole; DFO, deferoxamine; DMEM, Dulbecco’s-modified Eagle medium; DMOG, dimethyloxylalyglycine; EPO, erythropoietin; FBS, fetal bovine serum; FIH, factor inhibiting HIF; HIF, hypoxia-inducible fact
Transferrin receptor-1 suppresses neurite outgrowth in neuroblastoma Neuro2A cells
Keywords: DFO، deferoxamine; α-MEM, alpha modified minimum essential medium; apo-Tf, apo-transferrin; ATRA, all-trans retinoic acid; Dcytb, duodenal cytochrome-b; DFO, deferoxamine; DIV, days in vitro; DMEM, Dulbecco’s modified Eagle’s medium; DMT1, divalent metal transporter-1; FBS,
Nuclear coded mitochondrial protein prohibitin is an iron regulated iron binding protein
Keywords: DFO، deferoxamine; PHB, prohibitin; UTR, untranslated region; IRE, iron-response element; IRP, iron regulatory protein; FAC, ferric ammonium citrate; DFO, deferoxamine; GST, glutathione S-transferase; IL-6, interleukin 6; DAB, 3,3-diaminobenzidine tetrahydrochloride; TBHP,
Exposure to chrysotile asbestos causes carbonylation of glucose 6-phosphate dehydrogenase through a reaction with lipid peroxidation products in human lung epithelial cells
Keywords: DFO، deferoxamine; GSH, glutathione; G6PDH, glucose 6-phosphate dehydrogenase; DFO, deferoxamine; 4-HNE, 4-hydroxy-2-nonenal; MDA, malondialdehyde; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; t-BHP, t-butylhydroperoxide; TBARS, thiobarbituric acid-r
Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells
Keywords: DFO، deferoxamine; ALP, autophagy-lysosome pathway; AVO, acidic vesicular organelles; DFO, deferoxamine; GFP, green fluorescent protein; HIF1-α, hypoxia-inducible factor 1alpha; LC3, microtubule-associated protein light chain 3; MPP+, 1-methyl-4-phenylpyridinium ion; O2, Ox
Lipofuscin-bound iron is a major intracellular source of oxidants: Role in senescent cells
Keywords: DFO، deferoxamine; Ac-R-L-R-AMC, N-acetyl-Arg-Leu-Arg-7-amino-4-methylcoumarin; Ac-DEVD-AMC, N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin; DCF, 2′,7′-dichlorofluorescein; DFO, deferoxamine; DMPO, 5,5-dimethyl-1-pyrroline-N-oxide; DMSO, dimethyl sulfoxide; DTT, dithioth
Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone
Keywords: DFO، deferoxamine; CHAPS, [(cholamidopropyl)dimethylammonio]-1-propane-sulfonate; DFO, deferoxamine; DFP, deferiprone; FO, feroxamine; FP, feriprone; HPLC, high-performance liquid chromatography; HYSS, Hyperquad Simulation and Speciation program; LPI, labile plasma iron; ML
Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degeneration
Keywords: DFO، deferoxamine; AM, aminochrome; CV, column volume; DA, dopamine; DFO, deferoxamine; GSH, glutathione; GSSG, glutathione disulfide; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; SN, substantia nigra; PD, Parkinson disease; ROS, reactive oxygen specie
Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons
Keywords: DFO، deferoxamine; ALS, amyotrophic lateral sclerosis; DFO, deferoxamine; DMT1, divalent metal-ion transporter 1; IRE, iron-responsive element; IRP1, iron regulatory protein 1; LDH, lactate dehydrogenase; TBARS, thiobarbituric acid-reactive substances; TfR, transferrin rece
New insight into the influence of carob extract and gallic acid on hemin induced modulation of HT29 cell growth parameters
Keywords: DFO، deferoxamine; CAL, calcein; CDKN1A, cyclin-dependent kinase inhibitor 1A; CE, carob extract; DFO, deferoxamine; FCS, fetal calf serum; GA, gallic acid; GAPDH, glycerinaldehyd-3-phosphat-dehydrogenase; H2O2, hydrogen peroxideColorectal cancer; Iron; Heme; Ceratonia sili
Iron deficiency down-regulates the Akt/TSC1-TSC2/mammalian Target of Rapamycin signaling pathway in rats and in COS-1 cells
Keywords: DFO، deferoxamine; 4E-BP, eukaryote initiation factor 4E binding protein; DFO, deferoxamine; ID, iron deficiency; mTOR, mammalian Target of Rapamycin; Rheb, Ras homolog enriched in brain; S6K, S6 kinase; TSC, tuberous sclerosis complexIron deficiency (ID); mammalian Target
The role and regulation of hypoxia-inducible factor-1α expression in brain development and neonatal hypoxic–ischemic brain injury
Keywords: DFO، deferoxamine; ARD1, arrest-defective-1; ARNT, aryl hydrocarbon nuclear translocator; BBB, blood-brain barrier; BNIP3, BCL2/adenovirus E1B interacting protein 3; C-TAD, C-terminal domain; DFO, deferoxamine; 3,4-DHB, 3,4-dihydroxybenzoate; EPO, erythropoietin; EPOR, EPO
Polyol pathway mediates iron-induced oxidative injury in ischemic–reperfused rat heart
Keywords: DFO، deferoxamine; AAR, area at risk; AR, aldose reductase; ARI, aldose reductase inhibitor; ATP, adenosine triphosphate; CAL, coronary artery ligation; DFO, deferoxamine; GAPDH, glyceraldehydes-3-phosphate dehydrogenase; GSH, glutathione; HR, heart rate; HIF-1α, hypoxia in
Therapeutics for neonatal brain injury
Keywords: DFO، deferoxamine; AMPA, alpha-3amino-hydroxy-5-methyl-4-isoxazole propionic acid; CNS, central nervous system; DFO, deferoxamine; EPO, erythropoietin; GPx, glutathione peroxidase; HI, hypoxia-ischemia; HIF-1alpha, hypoxia inducible factor-1alpha; NMDA, N-methyl-d-aspartate
Regulation of hepcidin in HepG2 and RINm5F cells
Keywords: DFO، deferoxamine; IL-6, interleukin-6; LPS, lipopolysaccharide; Epo, erythropoietin; DFO, deferoxamine; TBST, tris-buffered saline containing Tween® 20Hepcidin; Pro-hepcidin; Iron metabolism; Pancreas; Liver
Iron supplementation protects against lead-induced apoptosis through MAPK pathway in weanling rat cortex
Keywords: DFO، deferoxamine; CNS, central nervous system; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated protein kinase; JNK, c-Jun N-terminal kinase; TUNEL, terminal transferase-mediated dUTP nick end-labeling; DFO, deferoxamine; DAB, diaminobenzidineLea
Vanadium Induces VL30 Retrotransposition at an Unusually High Level: A Possible Carcinogenesis Mechanism
Keywords: DFO، deferoxamine; VL30s, viral-like 30 elements; EGFP, enhanced green fluorescent protein; FACS, fluorescence-activated cell scanning; NAC, N-acetyl-cysteine; DFO, deferoxamine; enRTs, endogenous reverse transcriptases; DSB, double-strand break; ROS, reactive oxygen specie
Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition
Keywords: DFO، deferoxamine; BQ, 1,4-benzoquinone; DFO, deferoxamine; DMNQ, 2,3-dimethoxy-1,4-naphthoquinone; DPI, diphenyleneiodonium chloride; GSH, reduced glutathione; GSSG, glutathione disulfide; LDH, lactate dehydrogenase; NAC, N-acetyl cysteine; ROS, reactive oxygen species; SK
Iron chelator induces THP-1 cell differentiation potentially by modulating intracellular glutathione levels
Keywords: DFO، deferoxamine; DFO, deferoxamine; IL, interleukin; PMA, phorbol-12-myristate-13-acetate; MIM, mimosine; SR-A, scavenger receptor A; ERK, extracellular signal-regulated kinase; NAC, N-acetyl-cysteine; FC, ferric citrate; FN, fibronectine; DN, dominant-negative; PBS, phos
The superoxide dismutase inhibitor diethyldithiocarbamate has antagonistic effects on apoptosis by triggering both cytochrome c release and caspase inhibition
Keywords: DFO، deferoxamine; BHA, butylated hydroxyanisole; BSA, bovine serum albumin; Cyt c, cytochrome c; DCFH-DA, 2′,7′-dichlorodihydrofluorescein diacetate; DDC, diethyldithiocarbamate; DDT, dithiotreitol; DFO, deferoxamine; DiOC6(3), 3,3′-diethyloxacarbocyanine; DISC, death-indu